Last updated: July 31, 2024
Sponsor: Medical University Innsbruck
Overall Status: Active - Recruiting
Phase
N/A
Condition
Heart Disease
Dysrhythmia
Heart Defect
Treatment
N/AClinical Study ID
NCT05127720
1322/2020
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
implanted Microport TEO SR/DR or BOREA SR/DR pacemaker device
signed informed consent
Exclusion
Exclusion Criteria:
any contraindication to perform a cardiac CT examination
eGFR < 30 ml/min/1.73 m2
allergy against CT contrast medium
hyperthyreoism
inability of the patient to understand the study purpose and plan
inability of the patient to perform baseline examinations
pregnancy or breast-feeding; women with childbearing potential
estimated life expectancy below one year
Study Design
Total Participants: 300
Study Start date:
November 30, 2021
Estimated Completion Date:
November 30, 2032
Study Description
Connect with a study center
Medical University Innsbruck
Innsbruck, Tyrol 6020
AustriaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.